Long-term outcomes of infantile spasms in children treated with ketogenic diet therapy in combination with anti-seizure medications in a resource-limited region

ObjectiveDespite numerous guidelines, the overall outcome of infantile spasms is poor, with only a small number of patients being able to attend school. The purpose of this study was to investigate long-term outcomes. Patients had poor access to the recommended first-line anti-seizure medications (A...

Full description

Bibliographic Details
Main Authors: Jianxiang Liao, Zhanqi Hu, Sufang Lin, Xinguo Lu, Jialun Wen, Jing Duan, Dongfang Zou, Huafang Zou, Mei Yu, Liqin Liu, Xiaoying Qiao, Yuanzhen Ye
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-01-01
Series:Frontiers in Epidemiology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fepid.2022.1080068/full
_version_ 1797952164988977152
author Jianxiang Liao
Zhanqi Hu
Sufang Lin
Xinguo Lu
Jialun Wen
Jing Duan
Dongfang Zou
Huafang Zou
Mei Yu
Liqin Liu
Xiaoying Qiao
Yuanzhen Ye
author_facet Jianxiang Liao
Zhanqi Hu
Sufang Lin
Xinguo Lu
Jialun Wen
Jing Duan
Dongfang Zou
Huafang Zou
Mei Yu
Liqin Liu
Xiaoying Qiao
Yuanzhen Ye
author_sort Jianxiang Liao
collection DOAJ
description ObjectiveDespite numerous guidelines, the overall outcome of infantile spasms is poor, with only a small number of patients being able to attend school. The purpose of this study was to investigate long-term outcomes. Patients had poor access to the recommended first-line anti-seizure medications (ASMs), such as hormones (corticotropin or prednisolone/prednisone) and vigabatrin, and their alternative treatment was other ASMs and a ketogenic diet.MethodsPatients suffering from infantile spasms who had at least 2 years of medical records in the electronic medical record system between January 2014 and August 2022 were included in this study. Patient information was retrospectively reviewed. All patients had received ketogenic diet therapy (mainly classical ketogenic diet therapy). The ketogenic diet therapy was combined with ASMs not used as first-line therapies. The primary endpoint outcome measure was the number of patients with seizure freedom. The secondary measures included the duration of ketogenic diet therapy, choice of ASMs, and patient development at the last visit.ResultsA total of 177 patients with infantile spasms were included, and 152 (86%) of them had seizure freedom. The median duration from the first to the last hospital visit was 53.27 months, and the number of visits was 47.00. The median age at the initial hospital visit was 8.00 months, and the median age at initiation of the ketogenic diet was 17.73 months. At the last visit, the proportions of patients with neurodevelopmental delay, developmental epileptic encephalopathy, drug-resistant epilepsy, and generalized seizures increased significantly. The frequently used ASMs were topiramate, valproic acid, levetiracetam, nitrazepam, and vitamin B6 injection, while the recommended first-line drugs corticotropin and vigabatrin were rarely selected. The study duration of 9.5 years was divided into three periods but the prescription of ASMs did not change significantly between these periods.ConclusionsAlthough the seizure freedom rate was high with ketogenic diet therapy combined with non-standard ASMs, the patients had a significant neurodevelopmental delay at the last visit, which was, however, similar to that of standard treatment. To improve the outcomes of infantile spasms, multicenter clinical trials of the ketogenic diet as a first-line treatment in combination with non-standard ASMs are needed.
first_indexed 2024-04-10T22:42:01Z
format Article
id doaj.art-b114ba06745e4e608033ef9ae3d3ab09
institution Directory Open Access Journal
issn 2674-1199
language English
last_indexed 2024-04-10T22:42:01Z
publishDate 2023-01-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Epidemiology
spelling doaj.art-b114ba06745e4e608033ef9ae3d3ab092023-01-16T04:35:29ZengFrontiers Media S.A.Frontiers in Epidemiology2674-11992023-01-01210.3389/fepid.2022.10800681080068Long-term outcomes of infantile spasms in children treated with ketogenic diet therapy in combination with anti-seizure medications in a resource-limited regionJianxiang LiaoZhanqi HuSufang LinXinguo LuJialun WenJing DuanDongfang ZouHuafang ZouMei YuLiqin LiuXiaoying QiaoYuanzhen YeObjectiveDespite numerous guidelines, the overall outcome of infantile spasms is poor, with only a small number of patients being able to attend school. The purpose of this study was to investigate long-term outcomes. Patients had poor access to the recommended first-line anti-seizure medications (ASMs), such as hormones (corticotropin or prednisolone/prednisone) and vigabatrin, and their alternative treatment was other ASMs and a ketogenic diet.MethodsPatients suffering from infantile spasms who had at least 2 years of medical records in the electronic medical record system between January 2014 and August 2022 were included in this study. Patient information was retrospectively reviewed. All patients had received ketogenic diet therapy (mainly classical ketogenic diet therapy). The ketogenic diet therapy was combined with ASMs not used as first-line therapies. The primary endpoint outcome measure was the number of patients with seizure freedom. The secondary measures included the duration of ketogenic diet therapy, choice of ASMs, and patient development at the last visit.ResultsA total of 177 patients with infantile spasms were included, and 152 (86%) of them had seizure freedom. The median duration from the first to the last hospital visit was 53.27 months, and the number of visits was 47.00. The median age at the initial hospital visit was 8.00 months, and the median age at initiation of the ketogenic diet was 17.73 months. At the last visit, the proportions of patients with neurodevelopmental delay, developmental epileptic encephalopathy, drug-resistant epilepsy, and generalized seizures increased significantly. The frequently used ASMs were topiramate, valproic acid, levetiracetam, nitrazepam, and vitamin B6 injection, while the recommended first-line drugs corticotropin and vigabatrin were rarely selected. The study duration of 9.5 years was divided into three periods but the prescription of ASMs did not change significantly between these periods.ConclusionsAlthough the seizure freedom rate was high with ketogenic diet therapy combined with non-standard ASMs, the patients had a significant neurodevelopmental delay at the last visit, which was, however, similar to that of standard treatment. To improve the outcomes of infantile spasms, multicenter clinical trials of the ketogenic diet as a first-line treatment in combination with non-standard ASMs are needed.https://www.frontiersin.org/articles/10.3389/fepid.2022.1080068/fullepilepsyinfantile spasmsanti-seizure medicationsseizure freeketogenic dietoutcome
spellingShingle Jianxiang Liao
Zhanqi Hu
Sufang Lin
Xinguo Lu
Jialun Wen
Jing Duan
Dongfang Zou
Huafang Zou
Mei Yu
Liqin Liu
Xiaoying Qiao
Yuanzhen Ye
Long-term outcomes of infantile spasms in children treated with ketogenic diet therapy in combination with anti-seizure medications in a resource-limited region
Frontiers in Epidemiology
epilepsy
infantile spasms
anti-seizure medications
seizure free
ketogenic diet
outcome
title Long-term outcomes of infantile spasms in children treated with ketogenic diet therapy in combination with anti-seizure medications in a resource-limited region
title_full Long-term outcomes of infantile spasms in children treated with ketogenic diet therapy in combination with anti-seizure medications in a resource-limited region
title_fullStr Long-term outcomes of infantile spasms in children treated with ketogenic diet therapy in combination with anti-seizure medications in a resource-limited region
title_full_unstemmed Long-term outcomes of infantile spasms in children treated with ketogenic diet therapy in combination with anti-seizure medications in a resource-limited region
title_short Long-term outcomes of infantile spasms in children treated with ketogenic diet therapy in combination with anti-seizure medications in a resource-limited region
title_sort long term outcomes of infantile spasms in children treated with ketogenic diet therapy in combination with anti seizure medications in a resource limited region
topic epilepsy
infantile spasms
anti-seizure medications
seizure free
ketogenic diet
outcome
url https://www.frontiersin.org/articles/10.3389/fepid.2022.1080068/full
work_keys_str_mv AT jianxiangliao longtermoutcomesofinfantilespasmsinchildrentreatedwithketogenicdiettherapyincombinationwithantiseizuremedicationsinaresourcelimitedregion
AT zhanqihu longtermoutcomesofinfantilespasmsinchildrentreatedwithketogenicdiettherapyincombinationwithantiseizuremedicationsinaresourcelimitedregion
AT sufanglin longtermoutcomesofinfantilespasmsinchildrentreatedwithketogenicdiettherapyincombinationwithantiseizuremedicationsinaresourcelimitedregion
AT xinguolu longtermoutcomesofinfantilespasmsinchildrentreatedwithketogenicdiettherapyincombinationwithantiseizuremedicationsinaresourcelimitedregion
AT jialunwen longtermoutcomesofinfantilespasmsinchildrentreatedwithketogenicdiettherapyincombinationwithantiseizuremedicationsinaresourcelimitedregion
AT jingduan longtermoutcomesofinfantilespasmsinchildrentreatedwithketogenicdiettherapyincombinationwithantiseizuremedicationsinaresourcelimitedregion
AT dongfangzou longtermoutcomesofinfantilespasmsinchildrentreatedwithketogenicdiettherapyincombinationwithantiseizuremedicationsinaresourcelimitedregion
AT huafangzou longtermoutcomesofinfantilespasmsinchildrentreatedwithketogenicdiettherapyincombinationwithantiseizuremedicationsinaresourcelimitedregion
AT meiyu longtermoutcomesofinfantilespasmsinchildrentreatedwithketogenicdiettherapyincombinationwithantiseizuremedicationsinaresourcelimitedregion
AT liqinliu longtermoutcomesofinfantilespasmsinchildrentreatedwithketogenicdiettherapyincombinationwithantiseizuremedicationsinaresourcelimitedregion
AT xiaoyingqiao longtermoutcomesofinfantilespasmsinchildrentreatedwithketogenicdiettherapyincombinationwithantiseizuremedicationsinaresourcelimitedregion
AT yuanzhenye longtermoutcomesofinfantilespasmsinchildrentreatedwithketogenicdiettherapyincombinationwithantiseizuremedicationsinaresourcelimitedregion